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As populations are growing increasingly older, new groups of 
frail patients are emerging. Studies of these patient groups pro-
vide insight that might be useful in treatment but also describe 
characteristics of a population that has survived longer than 
their peers. 
It has been estimated that there will be a global increase 
from almost half a million centenarians in 2015 to between 13 
and 50 million during the 21st century (Robine and Cubaynes 
2017). Most currently available studies on centenarian hip 
fracture patients are based on patient populations that are too 
small to describe the evolution of the group.
Previous studies on hip fracture patients in general have 
showed that while the age-adjusted incidence in patients aged 
50 and older declined between 1993–1996 and 2001–2005, the 
incidence rate for patients aged above 90 more than doubled 
(Bergstrom et al. 2009). We describe temporal trends of inci-
dence and mortality for hip fractures in centenarian patients 
and compare this group with younger hip fracture patients 
with regards to comorbidities and mortality in order to gain 
a greater understanding concerning a group of patients that is 
expected to increase rapidly during the 21st century. The study 
was performed using information on the entire Danish popu-
lation including all hip fractures that occurred over a 17-year 
period. 
Patients and methods
Study population
The Danish National Patient Registry was searched for all 
patients in Denmark aged 18 years or above admitted with 
a hip fracture (ICD-10 codes DS720 [femoral neck], DS721 
Background and purpose — Several studies suggest a 
global increase of centenarians during the 21st century. We 
describe temporal trends of hip fracture incidence and mor-
tality in this group and compare these patients with a group 
of younger hip fracture patients with regards to comorbidi-
ties and mortality.
Patients and methods — The full study popula-
tion included all hip fractures that occurred in Denmark (n 
= 154,047) between 1996 and 2012. Patients aged 100 or 
above were identified (n = 507) and hip fracture patients 
between the ages of 70 to 99 years (n = 124,007) were used 
for comparison. Data were accessed from national registries. 
Trends in incidence over time were analyzed using a log-
linear regression model, mortality was analyzed using the 
Kaplan–Meier estimator and trends in mortality over time 
were analyzed using a log-binomial regression model to 
obtain relative risk estimates.
Results and interpretation — The centenarian patients 
had fewer comorbidities than the younger comparison group, 
but mortality was higher at all timepoints. There was no sta-
tistically significant change in mortality over time but the 
incidence of hip fracture among centenarians decreased 
during the same time period. Our findings describe the char-
acteristics of an emerging group of hip fracture patients and 
could be of use in the planning of healthcare in the years to 
come.
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[pertrochanteric], and DS722 [subtrochanteric]) from Janu-
ary 1, 1996 to December 31, 2012. The patients were only 
included once with the first hip fracture that occurred in this 
period. The full cohort consisted of 154,047 patients. From 
this cohort we identified 507 patients aged 100 years or above 
with a hip fracture during this period. We included all 124,007 
hip fracture patients between the ages of 70 and 99 years as a 
comparison group. Aggregated data on annual mortality rates 
for all individuals aged 99 years or older in the Danish popu-
lation were available from Statistics Denmark (Danmarks 
Statistik—statistikbanken.dk) and were included for addi-
tional comparison.
Data sources: national registries
All Danish citizens are registered in the Civil Registra-
tion System (CRS) using a unique 10-digit civil registration 
number (CRN). Demographic information such as vital status 
and emigration is available from the CRS on everyone resid-
ing legally in Denmark. Information from national registries 
can be linked for the unique individual using the CRN as it is 
used in all public records. In addition, birth date and sex can 
be extracted from the CRN.
In Denmark, all contacts and admissions to Danish hos-
pitals are registered in the Danish National Patient Registry 
(DNPR). This includes data on all somatic hospital admis-
sions dating back to 1977 and has since 1995 also included 
data on outpatient visits. The DNPR contains information on 
discharge diagnosis (only 1 is registered) or other secondary 
diagnostic codes in the form of International Disease Clas-
sification (ICD) codes (version 8 and 10). For this study, data 
from the DNPR were available from 1995 and onwards. 
A detailed description of the databases used can be found in 
a previous article (Madsen et al. 2016). Data from the national 
registries mentioned was accessed via Statistics Denmark.
Outcomes and covariates
For the endpoint mortality, date of admission was used as the 
index date for mortality rates. The patients were followed until 
death, emigration, or end of follow-up (November 13, 2014), 
whichever came first. For classification of cause of death in the 
centenarian cohort, we included information on the underlying 
cause of death as reported to the Danish Register of Causes 
of Death (Helweg-Larsen 2011). This information was avail-
able only for the 321 deaths occurring in the period 2002 to 
2012. Underlying causes of death were grouped according to 
the overall chapters of the ICD-10 classification as indicated. 
Comorbidity was included in the form of the Charlson 
Comorbidity Index (CCI) and the individual comorbidities 
making up the index. This was based on data from the DNPR, 
which records all hospital contacts. If a patient had a hospital 
contact registered in the DNPR before the time of the frac-
ture with 1 of the ICD-10 codes constituting the comorbidities 
in the CCI, the patient was listed as having that comorbidity. 
Hence, a CCI of 0 indicates that the patient has not had a hos-
pital contact registered in the DNPR with any of the comor-
bidities constituting the CCI. The coding of comorbidities 
and the ICD-10 codes used for the individual comorbidities 
were done as described by Quan et al. (2005). All prescription 
drugs sold in Denmark are registered in the Danish National 
Prescription Database (Kildemoes et al. 2011). Use of anti-
osteoporotic medication on admission was defined as retriev-
ing a prescription for antiosteoporotic medication (ATC code: 
M05B) during the last 6 months before the hip fracture date.
Statistics
Differences in baseline characteristics were analyzed using 
Pearson’s chi-squared test for categorical variables and the 
Mann–Whitney U-test for continuous variables. 
Yearly crude absolute incidence rates were calculated as the 
number of centenarian hip fracture cases each year divided 
by the total number of centenarians in the Danish population 
by January 1 each year and expressed as events per 1,000 
persons, as done in similar previous publications (Rosen-
gren et al. 2017). This gives a close estimate of the incidence 
rate obtained by summing up the individual’s person-time at 
risk, as the competing risk of dying is balanced by the new 
individuals that enter the group of persons above 100 years 
of age during the year. Only the first hip fracture during the 
study period after age 100 was included. Trends in incidence 
over time were analyzed using a log-linear regression model 
assuming a Poisson distribution. Including a dispersion 
parameter did not affect the model fit, and hence there was 
no overdispersion. The model was constructed as number of 
cases as a function of calendar year with number of persons at 
risk each year as offset. 
Mortality is given as the proportion of patients dead at cer-
tain timepoints and compared in univariate analysis using Pear-
son’s chi-squared test. Mortality was further analyzed using 
the Kaplan–Meier estimator and compared using the log-rank 
test. Median survival times were similarly estimated with the 
Kaplan–Meier estimator. Trends in 30-day and 1-year mortal-
ity over time were analyzed using a log-binomial regression 
model to obtain relative risk estimates. The model included 
the dichotomous variable death as a function of calendar year 
or calendar year, age, and sex. As the aim was to describe 
change in mortality over time and not to elucidate possible 
mechanisms or adjust for possible changes, only age and sex 
were included as additional covariates. This means that the 
reported estimates could be biased by residual confounding.
2-sided p-values < 0.05 were considered statistically signifi-
cant. All analyses and data management were conducted using 
SAS version 9.3 (SAS Institute, Cary, NC, USA) through a 
secure remote connection provided by Statistics Denmark.
Ethics, funding, and potential conflicts of interest
The study was approved by the Danish Data Protection Agency 
(j.nr. 2012-58-0004.) whereas ethical committee approval is 
not required for this type of observational study according to 
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1,029 days in the centenarian and comparison group respec-
tively (logrank p < 0.0001). The difference in median survival 
between male (70 days) and female (102 days) centenarians 
was not statistically significant (logrank p = 0.35). The under-
lying causes of deaths in the 321 centenarians dying in the 
period 2002 to 2012 are given in Table 2.
Temporal trends in incidence and mortality
The annual number of centenarian hip fracture patients in Den-
mark remained relatively stable and varied between 22 (2003 
and 2004) and 39 (2007). The overall incidence rate for the 
entire period was 47.0/1,000 persons. There was an estimated 
yearly decrease in the incidence rate of 3.4% (1.7–5.1%, p < 
0.001) over the entire study period (Figure 2). The mean age 
of all centenarians in the Danish population of 101 years was 
constant from 1996 to 2012. 
There was no statistically significant change in mortality per 
calendar year for either 30-day (–1.0% [–3.3 to 1.5], p = 0.4) 
or 1-year (–0.1% [–1.3 to 1.2], p = 0.9) mortality (Figure 3). 
Adjusting for the possible confounders age and sex had no sta-
tistically significant effect on the estimated yearly changes in 
Table 1. Basic characteristics for centenarians and comparison group. 
Values are frequency (%) unless otherwise specified
  Comparison
 Centenarians group p-value
n   507  124,007  NA
Women 431 (85.0) 91,439 (73.7)  < 0.001
Age (years), median (range) 101 (100–111) 83 (70–99)  NA
Charlson Comorbidity Index,
median (range) 0 (0–7) 1 (0–19)  < 0.001
Charlson Comorbidity Index   < 0.001
 0 344 (67.9) 56,451 (45.5)
 1 87 (17.2) 27,421 (22.1)
 2 46 (9.1) 19,796 (16.0)
 ≥ 3 30 (5.9) 20,339 (16.4)
Renal disease 2 (0.4) 2,192 (1.8) 0.01
Liver disease, mild 1 (0.2) 873 (0.7) 0.3
Liver disease, severe 0  217 (0.2) 1.0
Congestive heart failure 85 (16.8) 27,568 (22.2) 0.003
Myocardial infarction 21 (4.1) 7,622 (6.2) 0.06
DM wIith complications 3 (0.6) 2,918 (2.4) 0.005
DM without complications 8 (1.6) 8,567 (6.9) < 0.001
Cerebrovascular disease 50 (9.9) 18,322 (14.8) 0.002
Peripheral vascular disease 6 (1.2) 7,480 (6.0) < 0.001
Pulmonary disease 12 (2.4) 12,183 (9.8) < 0.001
Ulcer disease 18 (3.6) 7,074 (5.7) 0.04
Malignancy 22 (4.3) 13,836 (11.2) < 0.001
Solid metastatic tumor 1 (0.2) 1,488 (1.2) 0.04
Rheumatic disorders 6 (1.2) 4,670 (3.8) 0.002
Dementia 16 (3.2) 10,641 (8.6) < 0.001
Paralysis 0  335 (0.3) 0.7
Fracture type   0.06
 Femoral neck 273 (53.9) 73,125 (59.0)
 Pertrochanteric 203 (40.0) 43,569 (35.1)
 Subtrochanteric 31 (6.1) 7,299 (5.9)
Use of antiosteoporotics 6 (1.2) 7,921 (6.4) < 0.001
DM: Diabetes mellitus
Danish law. No funding was received for this study and 
authors have no potential conflicts of interest regarding 
this investigation.
Results
Patient characteristics
Comorbidities (Table 1)
A higher percentage of centenarian hip fracture patients 
had a Charlson Comorbidity Index (CCI) of 0 than was 
the case for the comparison group of patients between 
70 and 99 years of age. Of the centenarians, 68% had 
a CCI of 0 versus 46% in the comparison group and, 
similarly, a lower percentage of centenarians had scores 
of 1, 2, and ≥ 3 as well (17% vs. 22%, 9.1% vs. 16%, 
and 5.9% vs. 16% respectively), indicating fewer comor-
bidities among the centenarian hip fracture patients than 
their younger peers. 
Mortality
Of the 507 centenarian patients, 484 died during the fol-
low-up period (median: 924 days [385–2121]). Only 23 
centenarians were alive at the end of follow-up. 
The proportion of centenarian patients that had died 
within 30 days, 90 days, 1 years, 2 years, and 5 years 
were 34%, 49%, 66%, 78%, and 94% respectively. Mor-
tality was lower in the comparison group at all timepoints 
as expected: 11%, 19%, 31%, 42%, and 64% (all p < 
0.001). In comparison, for all individuals aged 99 years 
or above in the Danish population from 1996 to 2012 the 
annual mortality rate was 48% (Figure 1).
The median estimated survival time was 97 days and 
Table 2. Cause of death for centenarian hip fracture patients occur-
ring in the period 2002–2012 from the Danish Register of Causes of 
Death. Values are frequency (%)
Cause of death ICD-10 codes 
Diseases of the circulatory system I00–I99 94 (29)
External causes of morbidity and mortality 
(including falls and fractures) V01–Y98 75 (23)
Ill-defined and unknown causes of mortality R95–R99 65 (20)
Diseases of the respiratory system J00–J99 24 (7.5)
Mental and behavioral disorders F00–F99 22 (6.9)
Diseases of the digestive system K00–K93 11 (3.4)
Endocrine, nutritional, and metabolic 
 diseases E00–E90 8 (2.5)
Neoplasms C00–D48 7 (2.2)
Diseases of the blood and blood-forming 
organs and certain disorders involving the 
immune mechanism D50–D89 5 (1.6)
Diseases of the musculoskeletal system 
and connective tissue M00–M99 3 (0.9)
Certain infectious and parasitic diseases A00–B99 2 (0.6)
Diseases of the skin and subcutaneous 
 tissue L00–L99 2 (0.6)
Diseases of the genitourinary system N00–N99 2 (0.6)
Diseases of the nervous system G00–G99 1 (0.3)
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30-day (–0.5% [–2.9 to 1.9], p = 0.7) and 1-year (0.2% [–1.1 
to 1.4], p = 0.8) mortality. The data were also aggregated into 
4, 5-year time periods to account for yearly variations. There 
was no difference in 30-day and 1-year mortality between any 
of the time periods. Specifically, for the period 1996–2000 
compared with the period 2009–2012 the relative risk was 1.1 
[0.82–1.6, p = 0.4] for 30-day mortality and 0.98 [0.82–1.2, p 
= 0.8] for 1-year mortality.
Discussion
The incidence of hip fractures in centenarians in Denmark has 
decreased over the last 2 decades, but the mortality rate follow-
ing hip fracture among centenarians has remained unchanged 
aside from negligible yearly variations. In comparison with 
hip fracture patients between 70 and 99 years of age, the cen-
tenarians had fewer recorded comorbidities. Studies of these 
patient groups provide insight that might be useful in treat-
ment but also describe characteristics of a population that has 
survived longer than their peers. 
Studies on the limits of aging in humans have suggested that 
the maximal lifespan is approximately 115 years (Dong et al. 
2016). In that study, they investigated data from the Human 
Mortality Database with data from 40 countries and territories 
and found that while previous increases in life expectancy had 
been mainly due to decreases in early-life mortality, recent 
data show a decline in late-life mortality and it would seem 
that there is still potential for further development of increas-
ing life expectancy. 
Strengths and limitations
The primary limitations of the present study include the lack of 
information on covariates such as BMI, smoking, frailty, and 
other variables not available from the national registries. The 
information on comorbidities is based on hospital visits and 
hence does not consider comorbidities that have not led to a 
hospital visit. Therefore, comorbidities solely treated by gen-
eral practitioners and not leading to hospital contact will not 
be captured by the Charlson Comorbidity Index based on the 
registries. Another limitation includes the fact that the included 
patients were a mix of first and subsequent hip fractures, which 
could affect the mortality and comparability over time.
The strengths include the above-mentioned population-
based design and the use of the high-quality Danish registries. 
These allow extensive information with high validity on hip 
fracture diagnoses and mortality. Unlike retrospective chart 
reviews, the information can be collected in a completely 
unbiased way from the registries. 
Comparison with literature
Previous studies have shown that the incidence of hip fractures 
has shifted towards older age (Bergstrom et al. 2009) and that 
the group of nona- and octogenarians as hip fracture patients is 
increasing. In some respects, this has created a relatively new 
population of frail patients with this diagnosis. As is noted in 
the article by Bergström et al., this makes the population of 
hip fracture patients even less homogeneous and presents an 
increasing challenge in management. 
As centenarian hip fracture patients are an emerging patient 
population, there are not many previous studies regarding 
incidence and outcome; however, it is noted in 1 of the articles 
that hip fractures were the leading cause of hospital admission 
in centenarians (Rodriguez-Molinero et al. 2010). It was also 
noted that centenarians had a 7 times higher incidence of hip 
fractures than any other age group. The study included all 162 
centenarian hip fracture patients in Spain in 2005. The inci-
dence rate was 3.8 %, similar to the 4.7% in our study. How-
ever, they found a 16% 1-month mortality rate, approximately 
half of what we found.
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Figure 1. Kaplan–Meier survival curves after 
hip fracture for centenarians and comparison 
group of patients between 70 and 99 years of 
age.
Figure 2. Trend in hip fracture incidence for 
centenarians.
Figure 3. Temporal trends in mortality for 
centenarians.
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Italy and Spain are both among the countries with the high-
est life expectancies in the world. The centenarian age group 
in Italy has the highest rate of increase in numbers of the geri-
atric population. In a cohort of 7,830 centenarians collected 
between 2004 and 2011, the number of patients who suffered 
hip fractures was 259, giving an incidence rate of 23/1,000 
per year in contrast to the overall incidence rate of 47/1,000 
in our study (Mazzola et al. 2016). This is in line with a pre-
vious study where the incidence rates have been found to be 
much higher in Scandinavia than in the rest of Western Europe 
(Dhanwal et al. 2011). However, only patients who were dis-
charged alive were included in that study and there is no infor-
mation on in-hospital mortality. Patients were followed up for 
2 years and the probability of survival was 32% in the hip 
fracture cohort compared with 48% in the reference group of 
centenarians that did not suffer a hip fracture. In comparison, 
2-year survival in our study was considerably lower at 23%. 
The hazard function in the study by Mazzola et al. showed 
that the greatest risk was 3–4 months postoperatively with 
an approximation of the trends afterwards in line with previ-
ous literature stating that the greatest risk for mortality is in 
the first 3 months after surgery (Haentjens et al. 2010). In the 
study by Mazzola et al. (2016), 81% of the centenarians had 
a Charlson Comorbidity Index of 0 compared with 68% in 
our study. In a single-center study from Spain on risk factors 
and mortality rates comparing 33 centenarians with 99 nona-
genarian controls (Barcelo et al. 2018), they found that these 
groups had similar in-hospital outcomes but the centenarians 
had more postoperative complications. 3-month and 1-year 
mortality rates were approximately double with 41% and 21% 
at 3 months, and 62% and 30% for centenarians and nonage-
narians respectively. CCI was not different between the groups 
and while it is difficult to draw conclusions from such a small 
number of subjects it is noteworthy that the centenarians had 
fewer readmissions than the nonagenarians after 3 months and 
after 1 year. 
Concerning temporal trends, previous studies have shown 
regional differences in hip fracture incidence, which in the 
Western world seems to have stabilized and decreased during 
the latest decades whereas it has increased in the developing 
world (Morin et al. 2013). In Denmark specifically, the inci-
dence of hip fractures declined by about 20% between 1997 
and 2006 (Abrahamsen et al. 2010). Our study period coin-
cides with the widespread introduction of antiosteoporotic 
treatment and an increased focus on fracture prevention in the 
elderly, which may contribute to the declining incidence rates. 
Improvements in nutrition might also influence declining rates 
of hip fracture incidence during the study period. Also during 
the study period, there has been a decrease in smoking habits 
in Denmark (Ng et al. 2014), which might contribute posi-
tively to bone health.
Furthermore, and also in line with our results, showing no 
change in mortality rates over time, a Swedish population-
based study found that mortality following hip fracture had 
remained unchanged from 1995 to 2012 (Karampampa et al. 
2015). This also included the age group 95+, but no specific 
information was given for those aged 100 years or above.
Conclusions and implications
Our study is one of the largest conducted to date concern-
ing centenarian hip fracture patients. Mortality was higher in 
centenarians than in younger patients but seemed stable over 
time aside from slight variations from year to year. There 
was a yearly decrease in incidence rates for centenarian hip 
fractures over the entire study period. The centenarians in our 
study seemed to have fewer comorbidities than their younger 
counterparts. 
Our findings support the “compression of morbidity” 
hypothesis of aging (Fries 1980) for this patient group, as it 
seems that many have reached an advanced age while having 
few or no comorbidities. This would suggest that for many of 
the centenarians in this study, onset of morbidity occurred late 
and was relatively short before their death, occurring not long 
after their hip fracture. This could be an important consider-
ation in the planning of healthcare for the coming decades as 
patients are expected to reach increasingly higher ages, but 
the patients in this study who lived for more than 100 years 
had fewer registered diagnoses from hospital contacts than the 
younger hip fracture patients.
CMM, HLJ, and JBL designed the study. MM and CMM wrote the initial 
draft of the manuscript, CMM and HLJ performed statistical analysis and 
calculations, and all authors were involved in revisions of the manuscript.
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